摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-苄氧基苯基)-1-(2,4-二苄氧基-6-羟基苯基)丙-2-烯-1-酮 | 23243-67-6

中文名称
3-(4-苄氧基苯基)-1-(2,4-二苄氧基-6-羟基苯基)丙-2-烯-1-酮
中文别名
——
英文名称
2'-hydroxy-4,4',6'-tris(benzyloxy)chalcone
英文别名
2'-Hydroxy-4,4',6'-tribenzyloxy-chalkon;3-(4-benzyloxyphenyl)-1-(2,4-benzyloxy-6-hydroxyphenyl)prop-2-en-1-one;3-(4-benzyloxyphenyl)-1-(2,4-dibenzyloxy-6-hydroxyphenyl)prop-2-en-1-one;1-[2-Hydroxy-4,6-bis(phenylmethoxy)phenyl]-3-(4-phenylmethoxyphenyl)prop-2-en-1-one
3-(4-苄氧基苯基)-1-(2,4-二苄氧基-6-羟基苯基)丙-2-烯-1-酮化学式
CAS
23243-67-6
化学式
C36H30O5
mdl
——
分子量
542.631
InChiKey
POBAJWKYWOQRCS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    136-137 °C
  • 沸点:
    756.0±60.0 °C(Predicted)
  • 密度:
    1.226±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.3
  • 重原子数:
    41
  • 可旋转键数:
    12
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    65
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(4-苄氧基苯基)-1-(2,4-二苄氧基-6-羟基苯基)丙-2-烯-1-酮氢气二甲基二环氧乙烷 、 palladium(II) hydroxide 作用下, 以 四氢呋喃甲醇二氯甲烷二甲基亚砜丙酮 为溶剂, 反应 3.0h, 生成 山奈酚
    参考文献:
    名称:
    Study of Kaempferol Glycoside as an Insulin Mimic Reveals Glycon To Be the Key Active Structure
    摘要:
    Diabetes mellitus is increasing in prevalence with patient numbers rising throughout the world. Current treatments for-diabetes mellitus focus on control of blood glucose levels. Certain kinds of flavonoids or their glycosides stimulate cells to improve glucose uptake and lower blood glucose levels. We synthesized kaempferol 3-O-neohesperidoside (1) a naturally occurring substance present in Cyathea phalerata Mart., reported to mimic the action of insulin. Synthetic 1 promoted glucose uptake in the cultured cell line, L6. Further studies to determine the core structure responsible for this activity using synthetic compounds revealed neohesperidose to be the primary pharmacophore. These findings support the use of certain saccharides as a potential novel treatment for diabetes mellitus by replacing or supporting insulin.
    DOI:
    10.1021/ml100171x
  • 作为产物:
    参考文献:
    名称:
    NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS
    摘要:
    本发明提供了表儿茶素及相关多酚的新颖类似物,它们的各种官能化衍生物,以及它们的制备方法、包含这些化合物的组合物和它们的使用方法。
    公开号:
    US20160039781A1
点击查看最新优质反应信息

文献信息

  • Synthesis of Benzopyran-Fused Flavone Derivatives via Microwave-Assisted Intramolecular C–H Activation
    作者:Krisztina Kónya、Zoltán Sipos
    DOI:10.1055/s-0036-1591773
    日期:2018.4
    supported by microwave irradiation to produce fused tetracyclic flavones. In the case of the 7-substituted chrysin derivative, the regioselectivity of the coupling was also examined. A microwave-assisted intramolecular direct arylation method for the synthesis of benzopyran-fused flavone derivatives containing natural flavone backbones is described. Different polyalkoxy flavones were synthesized and functionalized
    献给TamásPatonay教授的纪念 抽象的 描述了一种微波辅助的分子内直接芳基化方法,用于合成含有天然黄酮骨架的苯并吡喃稠合的黄酮衍生物。合成了不同的聚烷氧基黄酮,并用2-溴苄基溴官能化。使得到的化合物经受由微波辐射支持的钯催化的分子内直接芳基化反应,以产生稠合的四环黄酮。在7-取代的菊花链衍生物的情况下,还检查了偶联的区域选择性。 描述了一种微波辅助的分子内直接芳基化方法,用于合成含有天然黄酮骨架的苯并吡喃稠合的黄酮衍生物。合成了不同的聚烷氧基黄酮,并用2-溴苄基溴官能化。使得到的化合物经受由微波辐射支持的钯催化的分子内直接芳基化反应,以产生稠合的四环黄酮。在7-取代的菊花链衍生物的情况下,还检查了偶联的区域选择性。
  • NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS
    申请人:SPHAERA PHARMA PVT. LTD.
    公开号:US20160039781A1
    公开(公告)日:2016-02-11
    The present invention provides novel analogues of epicatechin and related polyphenols, their variously functionalized derivatives, process for preparation of the same, composition comprising these compounds and their method of use.
    本发明提供了表儿茶素及相关多酚的新颖类似物,它们的各种官能化衍生物,以及它们的制备方法、包含这些化合物的组合物和它们的使用方法。
  • Synthesis of Inhibitors of P90Rsk
    申请人:Hecht Sidney M.
    公开号:US20080269144A1
    公开(公告)日:2008-10-30
    The synthesis of the naturally occurring kaempferol glycoside SLO1O1-1, as well as analogs thereof, has been accomplished, as has its biochemical evaluation. SLO1O1-1 exhibits selective and potent p90 Rsk inhibitory activity at nanomolar concentrations without inhibiting the function of upstream kinases such as MEK, Raf, or PKC. The synthetic scheme of the invention verified the structural assignment of the natural SLO1O1-1 product and has provided access to material sufficient for detailed biological evaluation.
    自然存在的山柰酚苷SLO1O1-1及其类似物的合成已经完成,并对其进行了生化评估。SLO1O1-1在纳摩尔浓度下表现出选择性和强效的p90 Rsk抑制活性,而不抑制MEK、Raf或PKC等上游激酶的功能。本发明的合成方案验证了天然SLO1O1-1产物的结构分配,并提供了足够详细的生物评估材料。
  • SYNTHESIS OF INHIBITORS OF P90RSK
    申请人:UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    公开号:EP1845778A2
    公开(公告)日:2007-10-24
  • US9975869B2
    申请人:——
    公开号:US9975869B2
    公开(公告)日:2018-05-22
查看更多